Building Blocks
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,774 products)
- Chiral Building Blocks(1,237 products)
- Hydrocarbon Building Blocks(6,098 products)
- Organic Building Blocks(60,970 products)
Found 205134 products of "Building Blocks"
4-formylbenzene-1-sulfonyl chloride
CAS:4-Formylbenzene-1-sulfonyl chloride is an alkylating agent that can be used to produce amines. It is the most efficient reagent for the reductive amination of carbonyl groups, and it also reacts with nucleophiles in a nucleophilic substitution reaction. The reaction of 4-formylbenzene-1-sulfonyl chloride with potassium carbonate produces formaldehyde and potassium sulfite. This product is soluble in water and organic solvents, which makes it useful for reactions involving high boiling points. Yields are typically 50%.Formula:C7H5ClO3SPurity:Min. 95%Molecular weight:204.6 g/mol2,5-Dioxo-5,6,7,8-tetrahydro-2H-chromene-3-carboxamide
CAS:2,5-Dioxo-5,6,7,8-tetrahydro-2H-chromene-3-carboxamide is a chromene that has been synthesized in the laboratory. It is stable and biologically active. This compound can be used to develop new pharmaceuticals or as an intermediate for other organic compounds.Formula:C10H9NO4Purity:Min. 95%Molecular weight:207.18 g/mol7,7-Dimethyl-2,5-dioxo-5,6,7,8-tetrahydro-2H-chromene-3-carbonitrile
CAS:Versatile small molecule scaffoldFormula:C12H11NO3Purity:Min. 95%Molecular weight:217.2 g/mol1-[4-Hydroxy-3-(piperidin-1-ylmethyl)phenyl]ethan-1-one hydrochloride
CAS:Versatile small molecule scaffold
Formula:C14H20ClNO2Purity:Min. 95%Molecular weight:269.77 g/mol2-(6-Sulfanylhexyl)-2,3-dihydro-1H-isoindole-1,3-dione
CAS:Diptocarpiline is a diterpene that is found in the bark of D. dasycarpa, a tree native to Southeast Asia. It has been shown to have anticonvulsant and analgesic properties, as well as anti-inflammatory effects. Daptocarpiline also has anticancer activity against leukemia cells in culture. This compound binds to the GABA receptor and inhibits the binding of GABA, which results in increased levels of this neurotransmitter in the brain. This leads to an increase in the frequency and amplitude of spontaneous inhibitory postsynaptic currents (sIPSCs) and an increase in the duration of action potentials (APs). The mechanism of anticancer activity is not completely understood, but it may be due to its ability to induce apoptosis by inhibiting protein synthesis or by inducing reactive oxygen species (ROS).Formula:C14H17NO2SPurity:Min. 95%Molecular weight:263.36 g/mol(2S)-2-Benzenesulfonamido-3-methylbutanoic acid
CAS:Versatile small molecule scaffold
Formula:C11H14NO4SPurity:Min. 95%Molecular weight:256.3 g/mol4-Azido-2-chloro-1-fluorobenzene
CAS:4-Azido-2-chloro-1-fluorobenzene (4ACFB) is a potential immunotherapy drug for cancer. It inhibits the activity of kynurenine, which is an important pathway in tumor growth and development. 4ACFB has been shown to inhibit the proliferation of human leukemia cells in vitro and in vivo. The half maximal inhibitory concentration for 4ACFB is 10 µM. This molecule also has high potential as a lead compound for cancer therapy because it targets many pathways that are involved in tumor growth and development, such as the microenvironment, protein synthesis, DNA replication, and cell division.Formula:C6H3ClFN3Purity:Min. 95%Molecular weight:171.56 g/mol1-Azido-4-methanesulfonylbenzene
CAS:1-Azido-4-methanesulfonylbenzene is a 1,3-dipolar cycloaddition agent that contains a heterocyclic ring. It inhibits the activity of the enzyme COX-2 (cyclooxygenase 2), which is the target for nonsteroidal anti-inflammatory drugs. 1-Azido-4-methanesulfonylbenzene has an inhibitory potency in the vicinal assay and has been shown to be a potent COX-2 inhibitor. The inhibition of COX-2 is thought to be due to its ability to bind with specificity to the heme group in the COX active site. This binding prevents substrate access and thus prevents prostaglandin synthesis.
Formula:C7H7N3O2SPurity:Min. 95%Molecular weight:197.22 g/mol1-[4-(1H-1,2,3-Triazol-1-yl)phenyl]ethan-1-one
CAS:Versatile small molecule scaffoldFormula:C10H9N3OPurity:Min. 95%Molecular weight:187.2 g/mol1-[3-(1H-1,2,3-Triazol-1-yl)phenyl]ethan-1-one
CAS:Versatile small molecule scaffoldFormula:C10H9N3OPurity:Min. 95%Molecular weight:187.2 g/mol8-Bromonaphthalene-1-carbaldehyde
CAS:8-Bromonaphthalene-1-carbaldehyde is a reactive intermediate in the synthesis of azepines. The compound has been shown to undergo reversible hydride transfer reactions with iodides and benzylic alcohols. It can be prepared by the reaction of 1,2-dibromoethane with acetophenone in the presence of sodium hydroxide. 8-Bromonaphthalene-1-carbaldehyde is also a useful synthon for the synthesis of azepines and active methylenes. 8-Bromonaphthalene-1-carbaldehyde reacts with 2,4,6-trimethylbenzenesulfonyl chloride to form 4-(2,4,6-trimethylphenyl)azepine.
Formula:C11H7BrOPurity:Min. 95%Molecular weight:235.08 g/mol1-(4-Methylbenzenesulfonyl)propan-2-ol
CAS:Versatile small molecule scaffoldFormula:C10H14O3SPurity:Min. 95%Molecular weight:214.28 g/mol2-(Bromomethyl)-2-methyloxolane
CAS:Versatile small molecule scaffoldFormula:C6H11BrOPurity:Min. 95%Molecular weight:179.05 g/mol2-Methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol
CAS:Versatile small molecule scaffoldFormula:C6H6N4OPurity:Min. 95%Molecular weight:150.14 g/mol4-(4-Methylpiperidin-1-yl)benzaldehyde
CAS:Versatile small molecule scaffoldFormula:C13H17NOPurity:Min. 95%Molecular weight:203.28 g/mol4-(4-Methylpiperidin-1-yl)benzonitrile
CAS:Versatile small molecule scaffoldFormula:C13H16N2Purity:Min. 95%Molecular weight:200.28 g/mol1-[3-(Methylsulfanyl)phenyl]urea
CAS:Versatile small molecule scaffoldFormula:C8H10N2OSPurity:Min. 95%Molecular weight:182.25 g/mol2-(5-Methyl-1,2-oxazol-3-yl)pyridine
CAS:Versatile small molecule scaffoldFormula:C9H8N2OPurity:Min. 95%Molecular weight:160.17 g/molMethyl 4-((tert-butoxycarbonyl)amino)butanoate
CAS:Versatile small molecule scaffoldFormula:C10H19NO4Purity:Min. 95%Molecular weight:217.26 g/mol4-(Adamantan-1-yl)-2,6-dichloroaniline
CAS:Versatile small molecule scaffold
Formula:C16H19Cl2NPurity:Min. 95%Molecular weight:296.2 g/mol5-tert-Butyl-2-methoxybenzonitrile
CAS:Versatile small molecule scaffoldFormula:C12H15NOPurity:Min. 95%Molecular weight:189.25 g/mol5-tert-Butyl-2-hydroxy-3-methoxybenzaldehyde
CAS:Versatile small molecule scaffold
Formula:C12H16O3Purity:Min. 95%Molecular weight:208.25 g/molN-{[2-(Trifluoromethyl)phenyl]methyl}cyclopentanamine
CAS:Versatile small molecule scaffoldFormula:C13H16F3NPurity:Min. 95%Molecular weight:243.27 g/molN-[(3-Fluorophenyl)methyl]cyclopentanamine
CAS:Versatile small molecule scaffoldFormula:C12H16FNPurity:Min. 95%Molecular weight:193.26 g/molBenzyl-(2,2,2-trifluoro-ethyl)-amine
CAS:Versatile small molecule scaffoldFormula:C9H10F3NPurity:Min. 95%Molecular weight:189.18 g/mol(3-Chloro-4-methoxyphenyl)thiourea
CAS:Versatile small molecule scaffold
Formula:C8H9ClN2OSPurity:Min. 95%Molecular weight:216.69 g/mol4-Chloro-3-nitro-1,5-naphthyridine
CAS:Versatile small molecule scaffold
Formula:C8H4ClN3O2Purity:Min. 95%Molecular weight:209.59 g/mol(2R,3R)-2-{[(tert-Butoxy)carbonyl]amino}-3-hydroxybutanoic acid
CAS:Pf-06305591 is a benzimidazole blocker that is being developed for the treatment of epilepsy. Pf-06305591 blocks sodium channels in the central nervous system, which are involved in neuronal excitability and seizure generation. This drug has been shown to be safe and well tolerated in preclinical studies. Pf-06305591 was discovered by optimizing chemical structures of phenylimidazole blockers, which have been shown to have efficacy against seizures but with a high incidence of adverse effects. Pf-06305591 has been shown to be effective at a dose that is well tolerated, with an optimized safety profile that can be individualized according to the patient's needs.Formula:C9H17NO5Purity:Min. 95%Molecular weight:219.23 g/mol4-(2,6-Dimethylmorpholin-4-yl)-3-fluoroaniline
CAS:Versatile small molecule scaffoldFormula:C12H17FN2OPurity:Min. 95%Molecular weight:224.27 g/mol2-Cyano-N-hexadecylacetamide
CAS:Versatile small molecule scaffoldFormula:C19H36N2OPurity:Min. 95%Molecular weight:308.5 g/mol[3-(Dimethylamino)-2,2-dimethylpropyl](methyl)amine
CAS:Versatile small molecule scaffoldFormula:C8H20N2Purity:Min. 95%Molecular weight:144.26 g/molN-[2-(Hydroxymethyl)phenyl]cyclopropanecarboxamide
CAS:Versatile small molecule scaffoldFormula:C11H13NO2Purity:Min. 95%Molecular weight:191.23 g/mol3-Chloro-N-(2-fluoro-5-nitrophenyl)propanamide
CAS:Versatile small molecule scaffoldFormula:C9H8ClFN2O3Purity:Min. 95%Molecular weight:246.62 g/molBicyclo[4.1.0]heptane-3-carboxylic acid
CAS:Versatile small molecule scaffold
Formula:C8H12O2Purity:Min. 95%Molecular weight:140.18 g/molN-(5-Bromopyrazin-2-yl)-2,2-dimethylpropanamide
CAS:Versatile small molecule scaffold
Formula:C9H12BrN3OPurity:Min. 95%Molecular weight:258.12 g/molN-(5-Acetylpyrazin-2-yl)-2,2-dimethylpropanamide
CAS:Versatile small molecule scaffoldFormula:C11H15N3O2Purity:Min. 95%Molecular weight:221.26 g/molN-(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide
CAS:Versatile small molecule scaffoldFormula:C14H22BNO4SPurity:Min. 95%Molecular weight:311.2 g/molMethyl 2-amino-5-(2-phenylethyl)-1,3-thiazole-4-carboxylate
CAS:Versatile small molecule scaffoldFormula:C13H14N2O2SPurity:Min. 95%Molecular weight:262.33 g/mol2-(3-Fluoro-5-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
CAS:Versatile small molecule scaffoldFormula:C12H15BFNO4Purity:Min. 95%Molecular weight:267.06 g/mol3-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
CAS:Versatile small molecule scaffoldFormula:C12H17BFNO2Purity:Min. 95%Molecular weight:237.08 g/mol8-Fluoro-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one
CAS:Versatile small molecule scaffoldFormula:C9H9FN2OPurity:Min. 95%Molecular weight:180.18 g/mol1H,2H,3H,4H,5H-Pyrido[3,4-b][1,4]diazepin-4-one
CAS:Versatile small molecule scaffoldFormula:C8H9N3OPurity:Min. 95%Molecular weight:163.18 g/mol4-Amino-1-ethylpiperidine-4-carbonitrile
CAS:Versatile small molecule scaffold
Formula:C8H15N3Purity:Min. 95%Molecular weight:153.22 g/mol8-(2,2,2-Trifluoroethyl)-1,4-dioxa-8-azaspiro[4.5]decane
CAS:Versatile small molecule scaffold
Formula:C9H14F3NO2Purity:Min. 95%Molecular weight:225.21 g/mol2-Chloro-5-methoxycarbonylphenylboronic acid pinacol ester
CAS:Versatile small molecule scaffoldFormula:C14H18BClO4Purity:Min. 95%Molecular weight:296.55 g/mol4-Methyl-3-(pyrrolidin-1-yl)aniline
CAS:Versatile small molecule scaffold
Formula:C11H16N2Purity:Min. 95%Molecular weight:176.26 g/mol3-[2-(Pyrrolidin-1-yl)ethyl]aniline
CAS:Versatile small molecule scaffold
Formula:C12H18N2Purity:Min. 95%Molecular weight:190.28 g/molPhenyl[4-(trifluoromethoxy)phenyl]methanamine
CAS:Versatile small molecule scaffoldFormula:C14H12F3NOPurity:Min. 95%Molecular weight:267.25 g/mol2-(4-Bromo-1H-pyrazol-1-yl)ethan-1-amine
CAS:Versatile small molecule scaffoldFormula:C5H8BrN3Purity:Min. 95%Molecular weight:190.04 g/moltert-butyl 4-[(oxan-4-yl)amino]piperidine-1-carboxylate
CAS:Versatile small molecule scaffoldFormula:C15H28N2O3Purity:Min. 95%Molecular weight:284.4 g/mol
